Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers

Journal of Infectious Diseases

Volumn 180, Issue 5, 1999, Pages 1459-1465

  McFarland, William ^a,e   Gwanzura, Lovemore ^f   Bassett, Mary T ^f   Machekano, Rhoderick ^f   Latif, Ahmed S ^f   Ley, Catherine ^c   Parsonnet, Julie ^c   Burke, Rae Lyn ^b,d   Katzenstein, David ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c STANFORD UNIVERSITY   (United States)

^d Biotechnology Solutions   (United States)

^e HIV Seroepidemiology Unit   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INDUSTRIAL WORKER; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL DISEASE; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SOCIOECONOMICS; ZIMBABWE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; INCIDENCE; INDUSTRY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; ZIMBABWE;

EID: 0032745301     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315076     Document Type: Article

References (27)

1. 1. Stanberrry LR, Jorgensen DM, Nahamias AJ. Herpes simplex viruses 1 and 2. In: Evans AS, Kaslow RA, eds. Viral infections of humans. 4th ed. New York: Plenum Publishing Corporation, 1997:419-54.
2. 2. Fleming DT, McQuillin GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
3. 3. Siegal D, Golden E, Washington AE, et al. Prevalence and correlates of herpes simplex infections: the population-based AIDS Multiethnic Neighborhoods study. JAMA 1992;268:1702-8.
4. 4. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990;162: 299-305.
5. 5. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as a serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-8.
6. 6. Wald A, Koutsky L, Ashley RL, Corey L. Genital herpes in a primary care clinic: demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997;24:149-55.
7. 7. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988;259:1048-50.
8. 8. Langeland N, Haarr L, Mhalu F. Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania. Int J Sex Transm Dis AIDS 1998;9: 104-7.
9. 9. Gwanzura L, McFarland W, Alexander D, Burke R-L, Katzenstein D. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis 1998;177:481-4.
10. 10. Hook EW III, Cannon RO, Nahamias AJ, et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992;165:251-5.
11. 11. Nelson KE, Eiumtrakul S, Celentano D, et al. The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand. J Acquir Immune Delic Syndr Hum Retroviol 1997;16:293-300.
12. 12. Nahmias AJ, Lee FK, Beckman-Nahamias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990;69(Suppl):19-36.
13. 13. Kamya M, Nsubuga P, Grant R, Hellman N. The high prevalence of genital herpes among patients with genital ulcer disease in Uganda. Sex Transm Dis 1995;22:351-4.
14. 14. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 1999;179:16-24.
15. 15. Wagner HU, Van-Dyck E, Roggen E, et al. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS 1994;5:332-7.
16. 16. Basset MT, McFarland W, Ray S, et al. Risk factors for HIV infection at enrollment in an urban male factory cohort in Harare, Zimbabwe. J Acquir Immune Defic Syndr Hum Retroviol 1996;13:287-93.
17. 17. Mbizvo M, Machekano R, McFarland W, et al. HIV seroincidence and correlates of seroconversion in a cohort of male factory workers in Harare, Zimbabwe. AIDS 1996;10:895-901.
18. 18. Katzenstein D, McFarland W, Mbizvo M, et al. Peer education among factory workers in Zimbabwe: a sustainable HIV prevention intervention. XII International Conference on AIDS. Geneva, June 1998 [abstract 540*/ 33514].
19. 19. Alexander D, Dinello R, Ashley R, et al. Simultaneous use of derivatives of glycoproteins gB1, gG1, gD2, gG2 as antigens for a type-specific serological assay to diagnose prior infection with HSV-1 or HSV-2. 96th Annual Society for Microbiology General Meeting. New Orleans, LA, May 1996 [abstract C101].
20. 20. Hayes R, Schulz K, Plummer F. The cofactor effect of genita ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. Am J Trop Med Hyg 1995;98:1-8.
21. 21. Kingsley LA, Armstrong J, Rahman A, Ho M, Rinaldo CR Jr. No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immun Defic Syndr 1990;773-9.
22. 22. Cowan FM, Johnson AM, Mindel A. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1993;167:772.
23. 23. Rompalo AM, Shepherd M, Lawlor JP, et al. Definitions of genital ulcer disease and variation in risk for prevalent human immunodeficiency virus infection. Sex Transm Dis 1997;24:436-42.
24. 24. Keet IPM, Lee FK, van Griensven GJP, Lange JMA, Nahamias AJ, Coutinho RA. Herpes simplex type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourin Med 1990;66:330-3.
25. 25. Heng MC, Heng SY, Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 1994;343: 255-8.
26. 26. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176:766-70.
27. 27. Augenbraum M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995;123:845-7.